220 related articles for article (PubMed ID: 21753072)
21. Familial pituitary adenomas - who should be tested for AIP mutations?
Korbonits M; Storr H; Kumar AV
Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
[TBL] [Abstract][Full Text] [Related]
22. The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.
Heliövaara E; Raitila A; Launonen V; Paetau A; Arola J; Lehtonen H; Sane T; Weil RJ; Vierimaa O; Salmela P; Tuppurainen K; Mäkinen M; Aaltonen LA; Karhu A
Am J Pathol; 2009 Dec; 175(6):2501-7. PubMed ID: 19850893
[TBL] [Abstract][Full Text] [Related]
23. Risk category system to identify pituitary adenoma patients with
Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
[TBL] [Abstract][Full Text] [Related]
24. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
[TBL] [Abstract][Full Text] [Related]
25. Large genomic deletions in AIP in pituitary adenoma predisposition.
Georgitsi M; Heliövaara E; Paschke R; Kumar AV; Tischkowitz M; Vierimaa O; Salmela P; Sane T; De Menis E; Cannavò S; Gündogdu S; Lucassen A; Izatt L; Aylwin S; Bano G; Hodgson S; Koch CA; Karhu A; Aaltonen LA
J Clin Endocrinol Metab; 2008 Oct; 93(10):4146-51. PubMed ID: 18628514
[TBL] [Abstract][Full Text] [Related]
26. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
[TBL] [Abstract][Full Text] [Related]
27. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A; Daly AF
Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
[TBL] [Abstract][Full Text] [Related]
28. AIP mutations and gigantism.
Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
[TBL] [Abstract][Full Text] [Related]
29. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
30.
Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
[TBL] [Abstract][Full Text] [Related]
31. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
[TBL] [Abstract][Full Text] [Related]
32. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
[TBL] [Abstract][Full Text] [Related]
33. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
[TBL] [Abstract][Full Text] [Related]
34. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman S; Ogret YD; Oguz FS
Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
[TBL] [Abstract][Full Text] [Related]
35. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
36. Update on the treatment of pituitary adenomas: familial and genetic considerations.
Daly AF; Beckers A
Acta Clin Belg; 2008; 63(6):418-24. PubMed ID: 19170361
[TBL] [Abstract][Full Text] [Related]
37. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
38. The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
Lloyd C; Grossman A
Endocrine; 2014 Aug; 46(3):387-96. PubMed ID: 24366639
[TBL] [Abstract][Full Text] [Related]
39. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
[TBL] [Abstract][Full Text] [Related]
40. Clinical and genetic aspects of familial isolated pituitary adenomas.
Vasilev V; Daly A; Naves L; Zacharieva S; Beckers A
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):37-41. PubMed ID: 22584704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
